Study uncovers new insights into pain pathways linked with temporomandibular joint disorders

Eli Lilly said the FDA wants the AdCom to better understand efficacy implications of its unique trial design. Image credit: Shutterstock / Jonathan Weiss Questions

Ad­dim­mune, a biotech that is work­ing on a cell ther­a­py for HIV, an­nounced Wednes­day that it plans to merge with 10X Cap­i­tal Ven­ture’s SPAC to be­come